BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B
BiohacksAI/Targets/MAPK13/Compounds

Compounds That Target MAPK13

mitogen-activated protein kinase 13 · 9 compounds in BiohacksAI corpus

MAPK13 (mitogen-activated protein kinase 13) is a biological target with 9 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into MAPK13 modulation for therapeutic and biohacking applications.

View MAPK13 target page →UniProt: O15264 ↗
Most Studied Compounds for MAPK13
1
Sorafenib
300+
studies
2
Isorhamnetin
300+
studies
3
Withaferin A
300+
studies
4
Anisomycin
247+
studies
All 9 Compounds — Ranked by Evidence
1
Foretinib
4.34
confidence
2
Doramapimod
4.06
confidence
3
Lestaurtinib
3.04
confidence
4
R 406
2.83
confidence
5
Ast 487
2.56
confidence
6
Sorafenib
300+
studies
1.10
confidence
7
Anisomycin
247+
studies
0.69
confidence
8
Isorhamnetin
300+
studies
0.69
confidence
9
Withaferin A
300+
studies
0.69
confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for MAPK13 (mitogen-activated protein kinase 13). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: MAPK13 target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.